GLP-1 receptor agonists (GLP-1 RAs), such as semaglutide, and GLP-1 dual/triple receptor agonists, such as Tirzepatide, have shown significant efficacy in treating type 2 diabetes and obesity
The comparison with Retatrutide is particularly relevant because both come from Eli Lilly and share the GIP/GLP-1 dual agonist foundation
This creates blood sugar spikes that tirzepatide is actively trying to prevent
Glucagon also promotes lipolysis, the breakdown of stored triglycerides into free fatty acids that your body can use for fuel
If a widely used metabolic drug class is now associated with better long-term survival and lower recurrence in selected breast cancer populations, that naturally raises questions about whether these agents could eventually become part of supportive or even adjunct oncologic care
For West Lafayette residents who may be prescribed Ozempic off-label for weight loss, we suggest switching to an FDA-approved weight loss medication